BELBIN, OLIVIA (IR)
OBelbin@santpau.cat
Cervantes Gonzalez, Alba IR
Imbastari, Francesca IR
Lidon Gil, Laia IR
Perlaza Meneses, Danna A. IR
BELBIN, OLIVIA (IR)
OBelbin@santpau.cat
Cervantes Gonzalez, Alba IR
Imbastari, Francesca IR
Lidon Gil, Laia IR
Perlaza Meneses, Danna A. IR
(JIF 2024)
-Fortea J, Pegueroles J, Alcolea D, Belbin O, Dols O, Vaqué L, Videla L, Gispert JD, Suárez M, Johnson SC, Sperling R, Bejanin A, Lleó A, Montal V. APOE4 homozygozity represents a distinct genetic form of Alzheimer’s disease. NATURE MEDICINE. 2024; DOI:10.1038/s41591-024-02931-w. PMID:38710950. IF:50,000 (Q1/1D). Document type: Article.
-Jácome D, Cotrufo T, Andrés P, Lidón L, Martí E, Ferrer I, del Río JA, Gavín R. miR-519a-3p, found to regulate cellular prion protein during Alzheimer ‘s disease pathogenesis, as a biomarker of asymptomatic stages. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2024; 1870(5):167187. DOI:10.1016/j.bbadis.2024.167187. PMID:38653354. IF:4,200 (Q1/2D). Document type: Article.
-Morcillo AO, Zsadanyi SE, Arriola JE, Carmona M, Montal V, Pegueroles J, Aranha MR, Vaque L, Padilla C, Benejam B, Videla L, Barroeta I, Fernandez S, Altuna M, Gimenez S, Gonzalez S, Bargallo N, Ribas L, Arranz J, Torres S, Iulita MF, Belbin O, Camacho V, Alcolea D, Lleo A, Fortea J, Bejanin A. Characterization of white matter hyperintensities in Down syndrome. Alzheimers & Dementia. 2024; 20(9). DOI:10.1002/alz.14146. PMID:39087352. IF:11,100 (Q1/1D). Document type: Article.
-Sirisi S, Sánchez E, Belbin O, Lleó A. APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets. Alzheimers Research & Therapy. 2024; 16(1):144. DOI:10.1186/s13195-024-01504-w. PMID:38951839. IF:7,600 (Q1/1D). Document type: Review.
-Zsadanyi SE, Morcillo-Nieto AO, Aranha MR, Aragón I, Arriola-Infante JE, Vaqué-Alcázar L, Montal V, Pegueroles J, Arranz J, Rodríguez-Baz Í, Blesa LM, Videla L, Barroeta I, Del Hoyo Soriano L, Benejam B, Fernández S, Hernandez AS, Bargallo N, González-Ortiz S, Giménez S, Alcolea D, Belbin O, Lleó A, Fortea J, Carmona-Iragui M, Bejanin A. Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome. Neurology. 2024; 103(4):e209676. DOI:10.1212/WNL.0000000000209676. PMID:39074338. IF:8,500 (Q1/1D). Document type: Article.
(JIF 2023)
-Colom M, Davies C, Sirisi S, Lee J-E, Simzer EM, Tzioras M, Querol M, Sánchez É, Chang YY, Holt K, McGeachan RI, Rose J, Tulloch J, Wilkins L, Smith C, Andrian T, Belbin O, Pujals S, Horrocks MH, Lleó A, Spires TL. Synaptic oligomeric tau in Alzheimer’s disease A potential culprit in the spread of tau pathology through the brain. NEURON. 2023; 111(14):2170-2183.e6. DOI:10.1016/j.neuron.2023.04.020. PMID:37192625. IF:14,700 (Q1/1D). Document type: Article.
-Ferrer P, Puertollano D, Querol M, Sánchez É, Valle N, Cervantes A, Nuñez R, Pegueroles J, Dols O, Iulita MF, Aldecoa I, Molina L, Sánchez R, Fortea J, Belbin O, Sirisi S, Lleó A. Amyloid precursor protein ßCTF accumulates in synapses in sporadic and genetic forms of Alzheimer’s disease. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2023; 49(1):e12879. DOI:10.1111/nan.12879. PMID:36702749. IF:4,000 (Q1/2D). Document type: Article.
-Goossens J, González AC, Dewit N, Lidón L, Fortea J, Alcolea D, Lleó A, Belbin O, Vanmechelen E. Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum. Alzheimers Research & Therapy. 2023; 15(1):186. DOI:10.1186/s13195-023-01336-0. PMID:37898760. IF:8,000 (Q1/1D). Document type: Article.
-Iulita MF, Bejanin A, Vilaplana E, Carmona M, Benejam B, Videla L, Barroeta I, Fernández S, Altuna M, Pegueroles J, Montal V, Valldeneu S, Gimenez S, González S, Torres S, El Bennadi SE, Padilla C, Aranha MR, Estelles T, Illán I, Belbin O, Valle N, Camacho V, Blessing E, Osorio RS, Videla S, Lehmann S, Holland AJ, Zetterberg H, Blennow K, Alcolea D, Clarimón J, Zaman SH, Blesa R, Lleó A, Fortea J. Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome. Brain Communications. 2023; 5(2):fcad074. DOI:10.1093/braincomms/fcad074. PMID:37056479. IF:4,100 (Q1/2D). Document type: Article.
(JIF 2022)
